A phase III, partially double-blinded study evaluating the efficacy and safety of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine in 546 patients with HBeAg-negative/anti-HBe-positive chronic hepatitis B.

Marcellin P., Lau G., Bonino F., Farci P., Hadziyannis S., Jin R., ...More

54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, BOSTON, MASSACHUSETTS, 24 - 28 October 2003, vol.38 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 38
  • City: BOSTON
  • Bursa Uludag University Affiliated: Yes